PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsMigraine disorders
MeSH D008881 - migraine disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D051270:Primary headache disorders
0 Companies
0 Drugs
Success rate
D008881: 
Migraine disorders
72 Companies
23 Drugs
$
Success rate
D020325:Migraine with aura
3 Companies
4 Drugs
$
Success rate
D020326:Migraine without aura
3 Companies
4 Drugs
$
Success rate
D060486:Ophthalmoplegic migraine
0 Companies
0 Drugs
Success rate
D062026:Alice in wonderland syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaFremanezumab Ajovy  2019-03-28 $434 M Y2023 
Almotriptan Almotriptan  2015-07-07   
Eletriptan Eletriptan  2017-06-27   
Rizatriptan Rizatriptan Benzoate  2012-12-31   
Sumatriptan Sumatriptan  2009-02-09   
Sumatriptan Zecuity 2023-02-21 2013-01-17   
PadagisDihydroergotamine Dihydroergotamine  2003-04-28   
Naratriptan Naratriptan  2010-07-08   
Sumatriptan Sumatriptan  2020-09-21   
Zolmitriptan Zolmitriptan  2021-09-30   
Glenmark PharmaceuticalsFrovatriptan Frovatriptan  2016-03-11   
Rizatriptan Rizatriptan Benzoate  2013-07-01   
Zolmitriptan Zolmitriptan  2013-05-14   
MylanAlmotriptan Almotriptan  2015-11-09   
Eletriptan Eletriptan  2017-08-11   
Frovatriptan Frovatriptan  2014-08-28   
Rizatriptan Rizatriptan Benzoate  2012-12-31   
Sumatriptan Sumatriptan  2009-11-02   
NATCO PharmaZolmitriptan Zolmitriptan  2013-05-14   
Rizatriptan Rizatriptan Benzoate  2012-12-31   
Johnson & JohnsonAlmotriptan Axert  2001-05-07   
GSKNaratriptan Amerge  1998-02-10   
Sumatriptan Imitrex  1995-06-01   
Sumatriptan Imitrex Statdose  1992-12-28   
CiplaDihydroergotamine Dihydroergotamine  2020-05-20   
Rizatriptan Rizatriptan Benzoate  2013-07-01   
Sumatriptan Sumatriptan  2021-02-22   
Zolmitriptan Zolmitriptan  2014-04-09   
Chartwell PharmaceuticalsCaffeine, Ergotamine Cafergot  1982-01-01   
Rizatriptan Rizatriptan Benzoate  2013-07-01   
Eletriptan Eletriptan  2017-08-29   
Naratriptan Naratriptan  2010-07-07   
SandozRizatriptan Rizatriptan Benzoate  2012-12-31   
Sumatriptan Sumatriptan  2009-02-06   
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
76%
39/51
Phase 2
67%
60/89
Phase 3
69%
74/108
Approved: 23Overall Success rate: 35%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Fremanezumab,
Sumatriptan,
Calcitonin
Mylan
Eletriptan,
Rizatriptan,
Sumatriptan
Johnson & Johnson
Almotriptan,
Flunarizine,
Soy isoflavones
GSK
Sumatriptan,
Naratriptan,
Docusate,
Enoblituzumab,
Dexibuprofen,
Aspartame,
Metaclopramide,
Histone-arginine methyltransferase carm1,
Surlorian,
Gw-274150
Sandoz
Enoblituzumab
Organon
Rizatriptan,
Caffeine,
Antineoplaston a10
AbbVie
Ubrogepant,
Atogepant,
Docusate,
Bevifimod,
MEDI0618,
Azzalure
AstraZeneca
Zolmitriptan,
Docusate,
Lotamilast,
Remetinostat,
Usistapide,
Rapimelt,
MEDI0618,
P2y purinoceptor 12
Novartis
Erenumab,
Heparin,
Caffeine,
Lidocaine,
Heparin sodium,
Calcitonin,
Levcromakalim,
SELURAMPANEL,
Globulin, immune,
Amg334
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use